Management tracks: MiMedx, Akorn, Mallinckrodt

Following a spate of resignations this summer, MiMedx Group Inc. (NASDAQ:MDXG) announced three executive promotions. SVP of Strategic Initiatives Mark Landy was promoted to EVP and chief strategy officer. VP of Medical Affairs David Mason was promoted to CMO. He succeeds Donald Fetterolf, who retired. MiMedx also said SVP of International Operations Jon Harris will become SVP of marketing and business management. Harris joined the regenerative medicine company in June and was previously VP and general manager at Cytori Therapeutics Inc. (NASDAQ:CYTX).

MiMedx said it is eliminating the position of chief commercial officer and Chris Cashman will leave the company...